agricultural chemicals manufacturer, opened today, August 18. The Crop Life Science IPO is an SME IPO and its subscription period ends on August 22. Crop Life Science aims to raise ₹26.73 crore for the IPO consisting of fresh issue of 51.40 lakh equity shares aggregating.
There is no offer for sale (OFS) component in the Crop Life Science IPO. Crop Life Science shares will be listed on the NSE EMERGE platform. Crop Life Science IPO price band has been fixed at ₹52 per equity share.
Check out Crop Life Science IPO subscription status, GMP today and other key details: Crop Life Science IPO has been subscribed 36% so far on Friday, the first day of the bidding process. The issue received bids for 17.48 lakh equity shares as against 51.40 lakh equity shares on the offer. The public issue was subscribed 77% times in the retail category, and 5% in the Non-Institutional Investors’ (NII) category.
The Qualified Institutional Buyers (QIB) are yet to bid for the IPO, till 2:00 PM. Also Read: Concord Biotech share price extends gain after listing at 21% premium. Buy, sell or hold? Crop Life Science IPO GMP today, or grey market premium today, is ₹3 per share, according to topsharebrokers.com.
This means that Crop Life Science IPO shares are trading higher by ₹3 in the grey market than their issue price. Considering the GMP today and the issue price, Crop Life Science shares listing is expected to be at ₹55 apiece ( ₹52 + ₹3). However, GMP alone is not the sole factor that can be used for making investment decisions.
It is just an indicative listing price, as per market observers. Crop Life Science IPO is a fixed price issue and the shares are sold at ₹52 apiece. The face value of Crop Life Science shares is ₹10 each.
Read more on livemint.com